You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 213 No. 3, July 20, 1970 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Diethylstilbestrol Therapy Gynecomastia

David A. Hendrickson, MD; W. Robert Anderson, MD
Minneapolis

JAMA. 1970;213(3):468.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor:—

Gynecomastia may complicate prolonged hormonal therapy for adenocarcinoma of the prostate. Formation of acinar tissue with secretory activity may also arise in the breast of a man, but examples have only rarely been cited. This unusual complication occurred in a patient developing marked breast enlargement concurrent with prolonged diethylstilbestrol (stilbestrol) therapy.

Report of a Case.—

A 62-year-old Negro was hospitalized at Hennepin County General Hospital in February 1969 for lumbosacral back pain attributed to metastatic prostatic carcinoma. Transurethral prostatectomy 13 years previously had revealed adenocarcinoma of the prostate. Following bilateral orchiectomy the patient received 5 mg of diethylstilbestrol daily continuously until December 1968 when bone survey confirmed osteoblastic lesions secondary to metastatic carcinoma throughout the vertebral column, clavicles, calvarium, and long bones of the extremities. Diethylstilbestrol administration was then increased to 15 mg three times daily for ten days and then tapered to 5 mg three times . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.